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Abstract In order to find out whether and how proteasomes
participate in the processes leading cerebellar granule cells to
death either in necrosis, due to glutamate neurotoxicity, or in
apoptosis, due to K+ shift, we measured the three proteasome
activities by using specific fluorescent probes and investigated the
effect of several proteasome inhibitors, including MG132, on the
cytochrome c release taking place in the early phase of both
apoptosis and necrosis. We show that differently from apoptosis,
the early phase of necrosis does not require proteasome
activation. Inhibition of proteasome activity can prevent
cytochrome c release in cerebellar granule cells undergoing
apoptosis, thus improving cell survival, but not necrosis. These
findings show that proteasomes play an important role in the
early phase of apoptosis but not that of necrosis, and that these
two types of cell death differ from each other in their
mechanism of cytochrome c release. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
One of the most outstanding problems in cell biology con-
cerns the mechanism by which cell death occurs. Apoptosis
and necrosis are two distinct modes of cell death that di¡er
from each other, the former being physiological and the latter
pathological. Since both inappropriate apoptosis and necrosis
are linked to neurodegenerative diseases including Alzheimer’s
and Parkinson’s diseases [1], the understanding of the molec-
ular events that make apoptosis and necrosis di¡erent is wor-
thy of special attention. In this regard, cultured rat cerebellar
granule cells (CGCs) represent an excellent in vitro model that
can be used to investigate the events underlying the two types
of cell death. Indeed, CGCs undergo necrotic death when
exposed to glutamate (GLU) and apoptotic death when the
extra-cellular concentration of KCl utilized for their culture
(25 mM) is reduced to 5 mM [2,3]. Both in apoptosis and in
necrosis, cytochrome c (cyt c) is early released into the cytosol
as an intact and functionally active protein from mitochondria
that are essentially coupled and intact [4^7]. Moreover, in
apoptosis, cyt c release has been found to be independent
on the activity of caspases that can degrade the released cyt
c accumulated in the cytosol [4].
Proteasomes play an important role in protein degradation
in all eukaryotic cells as it is a conserved multicatalytic pro-
teolytic complex [8,9]. Proteasome has been found to play a
crucial role during the early commitment phase of apoptosis
[10^12] and particularly in neuronal apoptosis [13,14], where-
as the role of proteasome in cell neurotoxicity is not known.
This prompted us to investigate whether and how proteasome
participates in some events leading CGCs to either necrosis or
apoptosis. In particular we investigated both the time-depen-
dent changes of proteasome activity in necrosis and apoptosis,
and the role of proteasome in cyt c release, showing that cyt c
release is strictly dependent on the proteasome activity in
apoptosis, but occurs in necrosis without proteasome involve-
ment.
2. Materials and methods
2.1. Reagents
MG132 (N-CBZ-Leu-Leu-Leu-Al), MG115 (N-CBZ-Leu-Leu-nor-
valinal), ALLM (N-Ac-Leu-Leu-methioninal), Suc-LLVY-MCA (suc-
cinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin), Boc-LSTR-MCA
(N-t-boc-Leu-Ser-threonin-arginin-7-amido-4-methylcoumarin) and
Z-LLE-LNap (N-CBZ-Leu-Leu-Glu-L-naphthylamide) were from Sig-
ma (St. Louis, MO, USA). LC (lactacystin) was purchased from Cal-
biochem (La Jolla, CA, USA). The addition of inhibitors or other
compounds was carried out concomitantly with either necrotic or
apoptotic treatment. The ¢nal concentration of dimethyl sulfoxide
(DMSO) was kept below 0.1%. Corresponding controls were treated
either with the same inhibitor or with the same concentration of
DMSO. Anti-cyt c antibodies (7H8-2C12) were purchased from
Pharmingen (San Diego, CA, USA). Anti-glutamate dehydrogenase
(GDH) antibodies were kindly supplied by Dr. F. Rothe (Institut fu«r
Medizinische Neurobiologie, University of Magdeburg, Magdeburg,
Germany).
2.2. Neuronal cultures
Primary cultures of CGCs were obtained from dissociated cerebel-
lar of 7-day-old Wistar rats as in [15]. Cells were plated in basal
medium with Eagle’s salts (BME; Life Technologies, Gaithersburg,
MD, USA) supplemented with 10% fetal bovine serum, 25 mM KCl
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and 2 mM glutamine (Life Technologies) on dishes (Nunc, Roskilde,
Denmark) coated with poly-L-Lysine. Cells were plated at 2U106 per
35 mm dish or 6U106 per 60 mm dish. 1L-Arabinofuranosylcytosine
(10 mM) was added to the culture medium 18^22 h after plating to
prevent proliferation of non-neuronal cells.
2.3. Induction of necrosis
Necrosis was induced as previously reported [2]. 6^7-day-in vitro
(DIV) cultures were exposed to 100 WM GLU for 30 min at 25‡C in
Locke’s solution (154 mM NaCl, 5.6 mM KCl, 3.6 mM NaHCO3, 2.3
mM CaCl2, 5.6 mM glucose, 10 mM HEPES, pH 7.4) in the presence
of 10 WM glycine. After this time, necrotic cells, referred to as GLU-
CGC, were replenished with the original conditioned medium and put
in the incubator. Control cells were treated as above but in the ab-
sence of GLU and are referred to as C-CGC.
2.4. Induction of apoptosis
Apoptosis was induced as in [3]. At 6^7 DIV, cells were washed
twice and switched to a serum-free BME, containing 5 mM KCl (K5)
and supplemented with 2 mM glutamine and 100 Wg/ml gentamycin
for the time reported in the ¢gure legends. Apoptotic cells are referred
to as S-K5 cells. Control cells were treated identically but maintained
in serum-free BME medium supplemented with 25 mM KCl (K25)
and are referred to as S-K25 cells.
2.5. Proteasome activity assay
Proteasomes can cleave peptides on the carboxyl side of hydropho-
bic, basic and acid residues. These proteolytic functions commonly
referred to as the chymotrypsin-, trypsin- and caspase-like activity,
can be measured by evaluating the hydrolysis of speci¢c £uorogenic
substrates [12,16,20]. Brie£y, CGCs were detached and lysed in a
bu¡er containing 20 mM Tris/HCl (pH 7.2), 0.1 mM EDTA, 1 mM
2-mercaptoethanol, 5 mM ATP, 20% glycerol, 0.04% Nonidet P-40 as
in [12,14,16]. After centrifugation, 10 Wg of the supernatants was used
for each assay. In particular, chymotrypsin-like activity was assayed
with 50 WM Suc-LLVY-MCA, trypsin-like activity was assayed with
100 WM Boc-LSTR-MCA and caspase-like activity was assayed with
400 WM Z-LLE-LNap for 20, 30 and 60 min respectively. In every case
the proteolytic activities were measured in a LS50 Perkin Elmer spec-
tro£uorimeter using the following wavelength pairs: 380 nm excita-
tion and 460 nm emission for MCA derivatives and 355 nm excitation
and 410 nm emission for LNap compounds.
Fig. 1. Proteasome activities in CGCs during apoptosis or necrosis. A: In order to induce necrosis, rat CGCs, cultured for 7 DIV, were incu-
bated in Locke’s solution in the presence of 100 WM GLU-CGC or with the same volume of Locke’s solution alone (C-CGC) for 30 min. After
this time, both necrotic (GLU-CGC) and control cells (C-CGC) were replenished with the original conditioned medium and put in the incuba-
tor for the indicated time. Where indicated, 1 WM MK801 was added simultaneously with GLU. B: In order to induce apoptosis, rat CGCs,
cultured for 7 DIV, were washed and incubated in serum-free medium with 25 mM KCl (S-K25, i.e. control cells) or switched to 5 mM KCl
serum-free medium (S-K5, i.e. apoptotic cells) for the indicated times. Both in the case of necrosis and apoptosis, at the time indicated after
the administration of the stimulus, supernatants were prepared from cell suspensions (see Section 2). 10 Wg supernatants was incubated with the
£uorogenic substrates speci¢c for chymotrypsin-like (Suc-LLVY-MCA), trypsin-like (Boc-LSTR-MCA) and caspase-like (Z-LLE-LNap) activ-
ities at 25‡C for 20, 30 and 60 min respectively. Speci¢c activities are expressed as the percentage of activities of control cells which have been
given a value of 100. Results are means þ S.D. of at least three separate experiments carried out with di¡erent cell preparations obtained from
di¡erent groups of animals.
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2.6. Western blot analysis
Immunoblot analysis was carried out on cytosolic extracts from
control (S-K25) and apoptotic cultures (S-K5), as in [4].
2.7. Oxygen uptake studies
O2 consumption was measured polarographically at 25‡C as in
[17,18] by means of a Gilson 5/6 oxygraph, using a Clark electrode.
The instrument sensitivity was set to a value which allowed us to
follow rates of O2 uptake as low as 0.5 natoms/min/mg cell protein.
2.8. Assessment of neuronal viability
Viable CGCs were quanti¢ed by counting the number of intact
nuclei after lysing the cells in detergent-containing solution as de-
scribed in [19].
3. Results
As already reported, proteasomes play a primary role in
CGCs undergoing apoptosis [14] with a slight but consistent
increase in the three peptidase activities of proteasome in the
early phase of cell death followed by a progressive decline. On
the other hand, it is still unknown whether and how protea-
some activity changes in GLU neurotoxicity. Thus, cells
undergoing necrosis (GLU-CGC), apoptosis (S-K5) and their
respective controls (C-CGC and S-K25 cells) were homoge-
nized and centrifuged with the chymotrypsin-, trypsin- and
caspase-like activity of the proteasome assayed in the super-
natant fractions as reported in Section 2 (Fig. 1). No change
in proteasome activities was found with respect to the control
in the early phase of GLU neurotoxicity (up to 30 min) or
when GLU neurotoxicity induction was prevented by MK801
((+)-5-methyl-10,1-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-
imine hydrogen maleate). After 1.5 h a progressive decline was
observed and a 20% decrease was detected at 2.5 h which
remained constant up to 4 h (Fig. 1A).
In close agreement with [14], proteasome activity time
Fig. 2. Cyt c release in CGCs undergoing either necrosis or apoptosis: e¡ect of MG132. A: In order to induce GLU neurotoxicity, rat CGCs,
cultured for 7 DIV, were incubated in Locke’s solution in the presence of 100 WM GLU-CGC or with the same volume of Locke’s solution
alone (C-CGC) for 30 min, either in the absence or presence of 5 WM MG132. B: In order to induce apoptosis, rat CGCs, cultured for 7 DIV,
were washed and incubated in serum-free medium with 25 mM KCl (S-K25, i.e. control cells) or switched to 5 mM KCl serum-free medium
(S-K5, i.e. apoptotic cells) for 3 h, either in the absence or presence of 5 WM MG132. In both apoptotic and necrotic conditions, cells were col-
lected, suspended in phosphate-bu¡ered saline and homogenized (see text for details). In A and B, a^c and aP^cP, aliquots (about 0.2 mg cell
protein) were incubated at 25‡C in the presence of rotenone (3 WM), antimycin (0.8 WM) and myxothiazole (6 WM) in a water-jacketed glass
vessel and oxygen consumption was started by adding 5 mM ascorbate (ASC). In A and B, d^f and dP^fP, homogenates were incubated at
25‡C in the presence of rotenone and oxygen consumption was started by adding 5 mM succinate. Then, ADP (0.5 mM) was added to verify
mitochondrial coupling. Numbers along the traces are rates of oxygen uptake expressed in natoms O2/min/mg cell protein. In ¢ve experiments,
carried out using di¡erent cell preparations, variations of up to 5% were found.
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courses in S-K5 cells show no signi¢cant change 1 h after
induction of apoptosis. However, 3 h after potassium shift,
a small but statistically signi¢cant activation of proteasome
activities was detected (Fig. 1B), followed by a progressive
reduction during incubation occurring up to 15 h, when the
values of the chymotrypsin-, trypsin- and caspase-like activity
were found to be 67 þ 2%, 51 þ 5%, and 64 þ 5% respectively.
In order to check whether proteasome can a¡ect cyt c re-
lease that occurs in the early phase of both necrosis and ap-
optosis, cyt c release was measured in the absence or presence
of some proteasome inhibitors at de¢nite times after death
induction. In the case of necrosis, analysis was performed
30 min after death induction when the proteasome activities
had not decreased yet. In apoptosis, analysis was performed
3 h after K deprivation, when maximum proteasome activa-
tion (this paper and [14]) and cyt c release [4] were reached. In
both cases, cyt c release was monitored by means of polaro-
graphic measurements of cyt c-dependent ascorbate oxidation
in cell homogenate [4^6] (Fig. 2).
In this case, the capability of CGC homogenate to oxidize
ascorbate at a higher rate than that of the control re£ects cyt c
release from mitochondria. In fact, ascorbate per se cannot be
oxidized by mitochondria in the absence of cyt c. Extra-mi-
tochondrial cyt c, once reduced by ascorbate, can induce oxy-
gen consumption via cyt c oxidase [6]. In agreement with [4^
7], both necrosis and apoptosis induction cause release of fully
functioning cyt c, as revealed by the increase in the rate of
ascorbate (5 mM) oxidation by necrotic and apoptotic cell
homogenates (Fig. 2A,B, b,bP) compared to control cells
(Fig. 2A,B, a,aP respectively; 12.5 and 4 natoms O2/min/mg
cell protein measured in GLU-CGC and in C-CGC respec-
tively; 15.8 and 3.3 natoms O2/min/mg cell protein measured
in S-K5 and in S-K25 respectively). Such an increase was
found to be statistically signi¢cant with a P6 0.05 value de-
tected in ¢ve and in four experiments carried out with GLU-
CGC and S-K5 cells respectively. Interestingly, externally
added MG132, a reversible proteasome inhibitor [21], was
found to prevent the increase in oxygen uptake due to ascor-
bate, i.e. cyt c release, in cells undergoing apoptosis (Fig. 2B,
cP), but not in those undergoing necrosis (Fig. 2A, c).
In the same experiment, as a control, the e¡ect of MG132
on succinate oxidation was also checked. In good agreement
with [17,18], GLU-CGC and S-K5 cell homogenates were
found to be less e¡ective than their respective controls when
both state 3 and state 4 respiration were measured (Fig. 2A,B,
e,eP as compared to d,dP). Interestingly, MG132 does not af-
fect electron £ow in the respiratory chain due to succinate
oxidation in any cell samples, either in state 4 or 3 (Fig.
2A,B, d-dP, and f,fP as compared to e,eP).
The release of cyt c was also investigated in S-K25 cells
treated with other proteasome inhibitors namely LC, a micro-
bial metabolite which irreversibly inhibits all three proteasome
activities [22], and MG115, the closely related MG132 inhib-
itor, which reversibly inhibits the proteolytic activities of pro-
teasome [21]. To account for the possible contribution to cyt c
release due to calpain and cathepsin, both partially inhibited
by MG132 and MG115, the e¡ect of ALLM on cyt c release
was also checked. ALLM is a permeable inhibitor of both
calpain and cathepsin.
All the proteasome inhibitors proved to be statistically sig-
ni¢cant (P6 0.001) in preventing cyt c release in apoptosis, as
polarographically measured (Fig. 3A). Similar results were
obtained with Western blot analysis carried out in parallel
on the cytosolic fractions (Fig. 3B). Polyclonal antibodies
against GDH were used to normalize the corresponding
amount of cyt c revealed on the same ¢lter as reported in
[4]. Cyt c release which occurs under apoptosis (S-K5, Fig.
3, lane b) was fully prevented by MG132, MG115 and LC
(Fig. 3, lanes d, e, f) but only to a low degree by ALLM (Fig.
3, lane c).
In order to ¢nd out whether proteasome inhibition can
somehow a¡ect the apoptosis time course, cell survival was
monitored in both S-K25 and S-K5 cells in the absence or
presence of the above reported inhibitors (Fig. 4). None of
them proved to a¡ect control cell survival for up to 15 h (not
shown). However, LC and MG132, but not ALLM, were
found to rescue cells from apoptosis.
Fig. 3. E¡ect of proteasome inhibitors on cyt c release in CGCs
undergoing apoptosis. Rat CGCs, cultured for 7 DIV, were incu-
bated either in high potassium or in low potassium serum-free cul-
ture medium for 3 h in the absence or presence of di¡erent inhibi-
tors: LC 100 WM, MG132 5 WM, MG115 5 WM, ALLM 40 WM.
A: Oxygen consumption was caused by externally added ascorbate.
Homogenates (about 0.2 mg protein) from either S-K25 or S-K5
cells were incubated at 25‡C in 1.5 ml phosphate-bu¡ered saline in
the presence of rotenone (3 WM), antimycin (0.8 WM) and myxothia-
zole (6 WM). Oxygen consumption was started by adding 5 mM as-
corbate and the initial rate of the reaction was expressed in natoms
O2/min/mg cell protein. Results are means þ S.D. of triplicate mea-
surements and are representative of at least six separate experiments
carried out with di¡erent cell preparations obtained from di¡erent
groups of animals. B: Western blot analysis of released cyt c. Cyto-
solic fractions from either S-K25 or S-K5 cells were analyzed by
Western blotting analysis. Antibodies against GDH were used to
normalize the amount of protein loaded onto the gel.
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In a parallel experiment, these inhibitors were found not to
a¡ect the release of cyt c or cell survival in CGCs undergoing
necrosis (not shown).
4. Discussion
In this paper we compare the proteasome activity time pro-
¢les in CGCs undergoing either necrosis or apoptosis, and,
moreover, we investigate the physiological role played by pro-
teasome in cyt c release that occurs in both types of cell death.
This study, together with [14], shows that the early phase after
apoptosis and necrosis induction in CGCs is accompanied by
a contrasting change in the three proteasome activities which
increase in apoptosis but show no signi¢cant change in ne-
crosis. For incubation longer times, a general decrease was
found in both types of cell death. We show that during
apoptosis proteasome is required to trigger the death pro-
cess, in fact when its activity is inhibited, both cyt c release
and neuronal death are prevented. Such a conclusion derives
from the inhibition experiments. In this regard, we rule out
any side e¡ect due to the inhibitors, such as electron £ow
impairment, in the light of the failure of all the inhibitors
used to a¡ect either oxygen consumption or mitochondrial
coupling in the succinate experiments. At present the protea-
some mechanism must remain a matter of speculation. Pro-
teasomes could act on unknown factors involved in cyt c
release, for instance Bcl2, which is a mitochondrial-localized
anti-apoptotic protein candidate, to undergo degradation via
proteasomes.
The picture that emerges from this paper and from [4] is
that the cytosolic level of the released cyt c in apoptosis is
controlled by at least two di¡erent proteolytic systems: (i) the
proteasome complex which mediates cyt c release (this paper)
and (ii) caspases which start to degrade cyt c accumulated in
the cytosol [4].
Furthermore, this paper gives a clear indication that pro-
teasomes are not involved in the early phase of necrosis pro-
gression and that they do not a¡ect cyt c release in this type of
cell death, as also con¢rmed by the ¢nding that proteasome
inhibitors fail to rescue CGCs undergoing excitotoxicity (Bob-
ba, Atlante, Marra, personal communication).
In the light of the ¢ndings reported in this paper, we con-
clude that the release of cyt c in CGCs undergoing necrosis or
apoptosis occurs in at least two distinct manners.
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